Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock Information | RedChip

Avadel Pharmaceuticals plc (NASDAQ: AVDL)


$11.9550
+0.2950 ( +1.66% ) 616.5K

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Market Data


Open


$11.9550

Previous close


$11.6600

Volume


616.5K

Market cap


$1.15B

Day range


$11.5050 - $12.1780

52 week range


$10.4100 - $19.0900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 08, 2023

Latest News